Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders
- PMID: 1638033
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders
Comment on
-
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.Blood. 1992 Jan 1;79(1):29-37. Blood. 1992. PMID: 1728318 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
